GlassScriptPhysician profile
Caroline K Han
NPI 1750328258
$1,017.39
in general payments reported to CMS, 2019-2025
14 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2021: $141 · 2023: $135 · 2024: $202 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $324.48 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $185.47 | 2019-2025 | Tezspire |
| Glaxosmithkline, LLC. | $163.69 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $121.06 | 2019 | |
| Astellas Pharma US INC | $30.68 | 2019 | |
| Novo Nordisk INC | $30.05 | 2019 | |
| Avanir Pharmaceuticals, INC. | $28.82 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.64 | 2019 | |
| Pfizer INC. | $28.16 | 2019 | |
| Vanda Pharmaceuticals INC. | $19.39 | 2021 | |
| Lilly USA, LLC | $15.77 | 2019 | |
| Sanofi Pasteur INC. | $14.53 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.93 | 2019 | |
| Stryker Corporation | $12.72 | 2023 | Infinity Adaptis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.